Filed: 8/14/2024ACC: 0001802630-24-000008
📋 What this filing means
SOLEUS CAPITAL MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 92 equity positions with a total reported market value of $1.13B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
92
Positions
$1.13B
Total AUM (reported)
119.08M
Total Shares
Allocation by class
COM$866.71M76.4%
COM NEW$88.95M7.8%
SPONSORED ADR$78.33M6.9%
COM STK$18.72M1.7%
CL A COM$13.98M1.2%
COM CL A$12.08M1.1%
SPONSORED ADS$10.01M0.9%
Portfolio Concentration
Top 3$170.46M15.0%
4–10$243.60M21.5%
11–25$310.37M27.4%
Rest$409.54M36.1%
Top 3 weight
15.0%
Top 10 weight
36.5%
Voting Authority Distribution
Total shares with voting rights: 119.08M
Sole
Full voting authority
119.08M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole92
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings92
Rows:
TG THERAPEUTICS INC
SOLEShares3.65M
TypeSH
Market value$64.85M
5.72%
Sole
3.65M
Shared
0.00
None
0.00
IOVANCE BIOTHERAPEUTICS INC
SOLEShares7.55M
TypeSH
Market value$60.53M
5.34%
Sole
7.55M
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares141.50K
TypeSH
Market value$45.07M
3.97%
Sole
141.50K
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares2.06M
TypeSH
Market value$42.91M
3.78%
Sole
2.06M
Shared
0.00
None
0.00
EDAP TMS S A
SOLEShares7.29M
TypeSH
Market value$39.68M
3.50%
Sole
7.29M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares4.95M
TypeSH
Market value$33.69M
2.97%
Sole
4.95M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares856.18K
TypeSH
Market value$33.23M
2.93%
Sole
856.18K
Shared
0.00
None
0.00
SURMODICS INC
SOLEShares781.78K
TypeSH
Market value$32.87M
2.90%
Sole
781.78K
Shared
0.00
None
0.00
ORGANOGENESIS HLDGS INC
SOLEShares11.52M
TypeSH
Market value$32.25M
2.84%
Sole
11.52M
Shared
0.00
None
0.00
JASPER THERAPEUTICS INC
SOLEShares1.28M
TypeSH
Market value$28.97M
2.55%
Sole
1.28M
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares694.07K
TypeSH
Market value$24.37M
2.15%
Sole
694.07K
Shared
0.00
None
0.00
AXOGEN INC
SOLEShares3.31M
TypeSH
Market value$23.93M
2.11%
Sole
3.31M
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares126K
TypeSH
Market value$23.14M
2.04%
Sole
126K
Shared
0.00
None
0.00
MERUS N V
SOLEShares376.32K
TypeSH
Market value$22.27M
1.96%
Sole
376.32K
Shared
0.00
None
0.00
PENUMBRA INC
SOLEShares123.45K
TypeSH
Market value$22.22M
1.96%
Sole
123.45K
Shared
0.00
None
0.00
ESSA PHARMA INC
SOLEShares4.21M
TypeSH
Market value$22.15M
1.95%
Sole
4.21M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares533.01K
TypeSH
Market value$22.05M
1.94%
Sole
533.01K
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares1.21M
TypeSH
Market value$19.84M
1.75%
Sole
1.21M
Shared
0.00
None
0.00
INARI MED INC
SOLEShares408.37K
TypeSH
Market value$19.66M
1.73%
Sole
408.37K
Shared
0.00
None
0.00
BEIGENE LTD
SOLEShares137.70K
TypeSH
Market value$19.65M
1.73%
Sole
137.70K
Shared
0.00
None
0.00
C4 THERAPEUTICS INC
SOLEShares4.05M
TypeSH
Market value$18.72M
1.65%
Sole
4.05M
Shared
0.00
None
0.00
CASTLE BIOSCIENCES INC
SOLEShares853.63K
TypeSH
Market value$18.58M
1.64%
Sole
853.63K
Shared
0.00
None
0.00
NEUROPACE INC
SOLEShares2.43M
TypeSH
Market value$18.39M
1.62%
Sole
2.43M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares769.26K
TypeSH
Market value$17.98M
1.59%
Sole
769.26K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares71.70K
TypeSH
Market value$17.42M
1.54%
Sole
71.70K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
TG THERAPEUTICS INCSOLE | COM | 3.65M | SH | $64.85M 5.72% | 3.65M | 0.00 | 0.00 |
IOVANCE BIOTHERAPEUTICS INCSOLE | COM | 7.55M | SH | $60.53M 5.34% | 7.55M | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 141.50K | SH | $45.07M 3.97% | 141.50K | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 2.06M | SH | $42.91M 3.78% | 2.06M | 0.00 | 0.00 |
EDAP TMS S ASOLE | SPONSORED ADR | 7.29M | SH | $39.68M 3.50% | 7.29M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 4.95M | SH | $33.69M 2.97% | 4.95M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 856.18K | SH | $33.23M 2.93% | 856.18K | 0.00 | 0.00 |
SURMODICS INCSOLE | COM | 781.78K | SH | $32.87M 2.90% | 781.78K | 0.00 | 0.00 |
ORGANOGENESIS HLDGS INCSOLE | COM | 11.52M | SH | $32.25M 2.84% | 11.52M | 0.00 | 0.00 |
JASPER THERAPEUTICS INCSOLE | COM NEW | 1.28M | SH | $28.97M 2.55% | 1.28M | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 694.07K | SH | $24.37M 2.15% | 694.07K | 0.00 | 0.00 |
AXOGEN INCSOLE | COM | 3.31M | SH | $23.93M 2.11% | 3.31M | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 126K | SH | $23.14M 2.04% | 126K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 376.32K | SH | $22.27M 1.96% | 376.32K | 0.00 | 0.00 |
PENUMBRA INCSOLE | COM | 123.45K | SH | $22.22M 1.96% | 123.45K | 0.00 | 0.00 |
ESSA PHARMA INCSOLE | COM NEW | 4.21M | SH | $22.15M 1.95% | 4.21M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 533.01K | SH | $22.05M 1.94% | 533.01K | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 1.21M | SH | $19.84M 1.75% | 1.21M | 0.00 | 0.00 |
INARI MED INCSOLE | COM | 408.37K | SH | $19.66M 1.73% | 408.37K | 0.00 | 0.00 |
BEIGENE LTDSOLE | SPONSORED ADR | 137.70K | SH | $19.65M 1.73% | 137.70K | 0.00 | 0.00 |
C4 THERAPEUTICS INCSOLE | COM STK | 4.05M | SH | $18.72M 1.65% | 4.05M | 0.00 | 0.00 |
CASTLE BIOSCIENCES INCSOLE | COM | 853.63K | SH | $18.58M 1.64% | 853.63K | 0.00 | 0.00 |
NEUROPACE INCSOLE | COM | 2.43M | SH | $18.39M 1.62% | 2.43M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 769.26K | SH | $17.98M 1.59% | 769.26K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 71.70K | SH | $17.42M 1.54% | 71.70K | 0.00 | 0.00 |
Page 1 of 4